Aridis Pharmaceuticals Reports Positive Preclinical Efficacy Data of a Highly Effective Inhaled Treatment Supporting a Proposed Self-Administered Therapy for COVID-19 Patients - PRNewswire Get link Facebook X Pinterest Email Other Apps October 21, 2020 Aridis Pharmaceuticals Reports Positive Preclinical Efficacy Data of a Highly Effective Inhaled Treatment Supporting a Proposed Self-Administered Therapy for COVID-19 Patients PRNewswire Get link Facebook X Pinterest Email Other Apps Comments
Comments
Post a Comment